Basic Information
LncRNA/CircRNA Name | HOXA11-AS |
Synonyms | NA |
Region | GRCh38_7:27184518-27189293 |
Ensemble | ENSG00000240990 |
Refseq | NR_002795 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | osteosarcoma |
ICD-0-3 | NA |
Methods | qRT-PCR , Luciferase reporter assay , Western blot etc. |
Sample | tumor tissues para-tumor tissues ,Human OS cell lines U2OS, MG-63 and KHOS, normal human osteoblast cell line Nhost |
Expression Pattern | up-regulated |
Function Description | HOXA11-AS expression levels in OS tissues and OS cell lines were higher than those in OS adjacent tissues and normal human osteoblast cell lines. The higher expression level of HOXA11-AS was positively correlated with more severe clinical stage, distant metastasis and poor prognosis of OS. Inhibition of HOXA11-AS expression could reduce metastasis and invasion of OS cell lines. In addition, HOXA11-AS was found to be an endogenous inhibitor of miR-125a-5p, it down regulated the expression level of miR-125a-5p, and this process could promote the expression of Rab3D, the target gene of miR-125a-5p. |
Pubmed ID | 31191012 |
Year | 2019 |
Title | The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma |
External Links
Links for HOXA11-AS | GenBank HGNC NONCODE |
Links for osteosarcoma | OMIM COSMIC |